We are in the process of making the following and other relevant articles
on MDMA neurotoxicity available at this site. The blue
underlined articles are available now. Bookmark
these pages. For further information please contact mario@lap.nl We are in the process of making the following and other relevant articles
on MDMA neurotoxicity available at this site. The blue
underlined articles are available now. Bookmark
these pages. For further information please contact mario@lap.nl
The effects of
3,4-Methylenedioxymethamphetamine (MDMA) and 3,4 methylenedioxyamphetamine (MDA) on
monoaminergic systems in the rat brain
1986
Donna M. Stone, Danese C. Stahl, R. Hanson and James W. Gibb
Methylenedioxymethamphetamine: A Potentially
Neurotoxic Amphetamine Analogue
1986
Christopher J. Schmidt, Lynne Wu and Walter Lovenberg
3,4-Methylenedioxymethamphetamine and
3,4-Methylenedioxyamphetamine Destroy Serotonin Terminals in Rat Brain: Quantification of
Neurodegeneration By Measurement of [³H]Paroxetine-Labeled Serotonin Uptake Sites
1987
George Battaglia, S. Y. Yeh, Elizabeth O'Hearn, Mark E. Molliver, Michael J. Kuhar
and Erroll B. De Souza
MDMA-Induced Neurotoxicity: Parameters of
Degeneration and Recovery of Brain Serotonin Neurons
1988
George Battaglia, S.Y. Yeh and Errol B. De Souza
Neurochemical and Neurohistological Alterations in
the Rat and Monkey Produced by Orally Administered Methylenedioxymethamphetamine (MDMA)
1988
William Slikker, Sved F. Ali, Andrew C. Scallet, Charles H. Frith, Glenn D. Newport and
J.R. Bailey
(±)3,4-Methylenedioxymethamphetamine Selectively
Damages Central Serotonergic Neurons on Nonhuman Primates
1988
George A. Ricaurte, Lysia S. Forno, Mary A. Wilson, Louis E. DeLanney, Ian Irwin,
Mark Molliver, J. William Langston
Neuroendocrine
and Mood Response to Intravenous (tryptophan) in (±)3,4-Methylenedioxymethamphetamine
(MDMA) Users
1989
Lawrence H. Price, , George A. Ricaurte, John Krystal and George Heninger
not yet available on line
Lasting Neuropsychiatric Sequelae of ( ± ) Methylenedioxymethamphetamine
('Ecstasy') in Recreational Users
1991
Una D. McCann, MD,¹ and George A. Ricaurte, MD, PhD²
MDMA: further evidence that its action in the medical
prefrontal cortex is mediated by the serotonergic system
1991
Helen S. Pan and Rex Y. Wang
Lasting Effects of (±)3,4-Methylenedioxymethamphetamine
(MDMA) on Central Serotonergic Neurons in Nonhuman Primates: Neurochemical Observations
1992
George A. Ricaurte, Anne L. Martello, Jonathan Katz and Mary A. Martello
The MDMA-Neurotoxicity Controversy: Implications for
Clinical Research with Novel Psychoactive Drugs
1992
Charles S. Grob, Gary L. Bravo, Roger N. Walsh and Mitchell B. Liester
Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use:
Effects on Mood and Neuropsychological Function?
1992
John H. Krystal and Lawrence H. Price
Pharmacology and Sleep: Persistent Effects of
(±)3,4-Methylenedioxymethamphetamine (MDMA) on Human
Sleep
1993
Richard P. Allen, Una D. McCann and George A. Ricaurte
Serotonin Neurotoxicity after
(±)3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): A Controlled Study in
Humans
1994
Una D. McCann, Alison Ridenour, Yavin Shaham and George Ricaurte
3,4-Methylenedioxymethamphetamine (MDMA,
"Ecstasy"): pharmacology and toxicology in animals and humans
1994
Thomas D. Steele, Una D. McCann & George A. Ricaurte
The spin trap reagent a-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of
S-hydroxytryptamine neurones
1995
Maria Isabel Colado, A. Richard Green
The
hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine
(MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype
1995
M.I. Colado, J.L. Williams & A.R. Green
not yet on line
Reorganization
of Ascending 5-HT Axon Projections in Animals Previously Exposed to the Recreational Drug
(±)3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
1995
G. Fischer, G. Hatzidimitriou, J. Wlos, J.Katz and G. Ricaurte
not yet on line
Review
of the pharmacology and clinical pharmacology of 3,4-Methylenedioxymethamphetamine
(MDMA or "Ecstasy")
1995
A. Richard Green - Alan J. Cross - Guy M. Goodwin
not yet on line
Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans:
methodological considerations and preliminary observations
1996
Charles S. Grob, Russell E. Poland, Linda Chang, Thomas Ernst
Neuropsychiatric Manifestations
Following the Use of 3,4-Methylenedioxymethamphetamine
(MDMA: "Ecstasy")
1997
Richard S. Cohen and James Cocores
Causes and consequences of the loss of
serotonergic presynapses elicited by the consumption of 3,4-Methylenedioxymethamphetamine
(MDMA: "Ecstasy")
1997
G. Huenther, D. Zhou and E. Rüther
24 MDMA
1997
Charles S. Grob and Russell E. Poland
Ecstasy (MDMA) in Recreational Users: Self-Reported
Psychological and Physiological Effects
1997
D. Davison and A.C. Parrott
Serotonergic function after
(±)3,4-methylene-dioxymethamphetamine ("Ecstasy") in humans
1997
G. Gerra, A. Zaimovic, G. Giucastro, D. Maestri, C. Monica, R. Sartori, R. Caccavari and
R. Delsignore
Mood and
cognitive effects of (±)3,4-methylene-dioxymethamphetamine
(MDMA "Ecstasy"): week-end 'high' followed by mid-week low
1997
H. Valerie Curran & Ross A. Travill
not yet on line
An Integrated Hypothesis for the Serotonergic Axonal
Loss Induced by 3,4 Methylenedioxymethamphetamine
1998
Jon E. Sprague, Shannon L. Everman and David E. Nichols
Ecstasy:
Des données biologiques et cliniques aux contextes d'usage
Synthèse et recommandations (French)
1998
INSERM (Institut National de la Santé et de la Recherche Medicale) France
not yet on line
Recreational
Use of "Ecstasy" (MDMA) is Associated with Elevated Impulsivity
1998
Michael J. Morgan
not yet on line
Cognitive performance in recreational users of MDMA
or 'ecstasy': evidence for memory deficits
1998
A.C. Parrott, A. Lees, N.J. Garnham, M. Jones and K. Wesnes
Neurotoxicité de
l’« ecstasy » : la science, la prévention et les jeunes. (french)
1999
Bertrand Lebeau
the mdma neurotoxicity archive and debate pages
another drugtext foundation substance use
information project